Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1993-4-21
|
pubmed:abstractText |
Accumulating evidence suggests that c-kit and its ligand, stem cell factor (SCF), play an important role in the regulation of at least three lineages of stem cell growth and possibly in leukemogenesis, while only limited data are available that suggest possible involvement of c-kit/SCF in the development of human solid tumors such as lung cancer. We have recently reported that c-kit is aberrantly expressed almost exclusively in small-cell lung cancer (SCLC) among various types of solid tumors. The present study revealed that c-kit protein ectopically expressed in SCLC is indistinguishable from that in leukemia cell lines with megakaryocytic characteristics with respect to amount, molecular size, and autophosphorylation status in response to recombinant human SCF. Furthermore, significant chemotactic response as well as moderate in vitro cell growth was induced in SCLC cell lines by the addition of recombinant human SCF, suggesting that c-kit/SCF may play an important biological role in the development of SCLC. Our extensive search for activating mutations naturally occurring in the c-kit gene revealed an amino acid substitution in the transmembrane domain of an SCLC cell line, although the functional consequences of this variant allele are yet to be determined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hematopoietic Cell Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-kit,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Stem Cell Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
53
|
pubmed:geneSymbol |
c-kit
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1709-14
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:7680956-Carcinoma, Small Cell,
pubmed-meshheading:7680956-Cell Division,
pubmed-meshheading:7680956-Chemotaxis,
pubmed-meshheading:7680956-Hematopoietic Cell Growth Factors,
pubmed-meshheading:7680956-Humans,
pubmed-meshheading:7680956-Leukemia,
pubmed-meshheading:7680956-Lung Neoplasms,
pubmed-meshheading:7680956-Phosphorylation,
pubmed-meshheading:7680956-Proto-Oncogene Proteins,
pubmed-meshheading:7680956-Proto-Oncogene Proteins c-kit,
pubmed-meshheading:7680956-Recombinant Proteins,
pubmed-meshheading:7680956-Sequence Analysis,
pubmed-meshheading:7680956-Stem Cell Factor,
pubmed-meshheading:7680956-Tumor Cells, Cultured
|
pubmed:year |
1993
|
pubmed:articleTitle |
Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
|
pubmed:affiliation |
Laboratory of Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|